SK16342000A3 - Liečivo na liečbu zápalového ochorenia čreva obsahujúce 1H-indol-3-glyoxylamidy - Google Patents
Liečivo na liečbu zápalového ochorenia čreva obsahujúce 1H-indol-3-glyoxylamidy Download PDFInfo
- Publication number
- SK16342000A3 SK16342000A3 SK1634-2000A SK16342000A SK16342000A3 SK 16342000 A3 SK16342000 A3 SK 16342000A3 SK 16342000 A SK16342000 A SK 16342000A SK 16342000 A3 SK16342000 A3 SK 16342000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- amino
- indol
- oxy
- dioxoethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8387498P | 1998-05-01 | 1998-05-01 | |
| PCT/US1999/008654 WO1999057100A1 (en) | 1998-05-01 | 1999-04-20 | Spla2 inhibitor compounds for treatment of disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK16342000A3 true SK16342000A3 (sk) | 2002-04-04 |
Family
ID=22181224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1634-2000A SK16342000A3 (sk) | 1998-05-01 | 1999-04-20 | Liečivo na liečbu zápalového ochorenia čreva obsahujúce 1H-indol-3-glyoxylamidy |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6340699B1 (zh) |
| EP (1) | EP1084108A4 (zh) |
| JP (1) | JP2002513783A (zh) |
| KR (1) | KR20010043190A (zh) |
| CN (1) | CN1299348A (zh) |
| AU (1) | AU3656299A (zh) |
| BR (1) | BR9910095A (zh) |
| CA (1) | CA2330856A1 (zh) |
| CZ (1) | CZ20004052A3 (zh) |
| EA (1) | EA200001140A1 (zh) |
| HR (1) | HRP20000739A2 (zh) |
| HU (1) | HUP0102243A2 (zh) |
| ID (1) | ID27153A (zh) |
| IL (1) | IL139019A0 (zh) |
| NO (1) | NO20005479L (zh) |
| PL (1) | PL343708A1 (zh) |
| SK (1) | SK16342000A3 (zh) |
| TR (1) | TR200003194T2 (zh) |
| WO (1) | WO1999057100A1 (zh) |
| ZA (1) | ZA200005563B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19962300A1 (de) * | 1999-12-23 | 2001-06-28 | Asta Medica Ag | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
| WO2001055108A2 (en) * | 2000-01-25 | 2001-08-02 | Eli Lilly And Company | Use of spl a2 inhibitors for the treatment of inflammation |
| AU2001267823A1 (en) | 2000-06-29 | 2002-01-08 | Shionogi And Co., Ltd. | Compounds exhibiting x-type spla2 inhibiting effect |
| WO2002007791A2 (en) * | 2000-07-24 | 2002-01-31 | Dow Global Technologies Inc. | Thermoplastic superabsorbent polymer blend compositions and their preparation |
| JP2009515837A (ja) * | 2005-11-03 | 2009-04-16 | イリプサ， インコーポレイテッド | Ｃ４−酸性置換基を有するインドール化合物およびホスホリパーゼａ２インヒビターとしてのその使用 |
| WO2009123080A1 (ja) * | 2008-04-01 | 2009-10-08 | アステラス製薬株式会社 | インドリノン化合物 |
| MY198422A (en) | 2009-04-29 | 2023-08-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| US9290752B2 (en) | 2013-03-13 | 2016-03-22 | Sunny Delight Beverages Co. | Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356919A (en) | 1991-05-30 | 1994-10-18 | G. D. Searle & Co. | Leukotriene B4 synthesis inhibitors |
| DE4218096A1 (de) | 1992-06-02 | 1993-12-09 | Boehringer Mannheim Gmbh | Spiro-oxetane, Verfahren zu ihrer Herstellung und Arzneimittel |
| DE4323409A1 (de) | 1993-07-13 | 1995-01-19 | Boehringer Mannheim Gmbh | Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel |
| PL180523B1 (pl) * | 1994-04-01 | 2001-02-28 | Eli Lilly & Co | Nowy zwiazek, pochodna 1H-indolo-3-glioksylamidu i srodek farmaceutyczny PL PL PL PL PL PL PL PL PL PL |
| WO1995033462A1 (en) * | 1994-06-02 | 1995-12-14 | Smithkline Beecham Corporation | Anti-inflammatory compounds |
| NZ298145A (en) * | 1994-12-29 | 1998-08-26 | Yamanouchi Pharma Co Ltd | Monoclonal antibodies having inhibitory effect on type ii phospholipase a2, proteins forming part thereof, cells producing them, dna encoding them, recombinant vector comprising the dna and medicament |
| TR199900956T2 (xx) | 1996-10-30 | 1999-07-21 | Eli Lilly And Company | S�bstit�e edilmi� trisiklik bile�imler. |
| EP1062205A2 (en) * | 1998-02-25 | 2000-12-27 | Genetics Institute, Inc. | Inhibitors of phospholipase enzymes |
-
1999
- 1999-04-20 ID IDW20002214A patent/ID27153A/id unknown
- 1999-04-20 CZ CZ20004052A patent/CZ20004052A3/cs unknown
- 1999-04-20 SK SK1634-2000A patent/SK16342000A3/sk unknown
- 1999-04-20 CA CA002330856A patent/CA2330856A1/en not_active Abandoned
- 1999-04-20 BR BR9910095-9A patent/BR9910095A/pt not_active Application Discontinuation
- 1999-04-20 TR TR2000/03194T patent/TR200003194T2/xx unknown
- 1999-04-20 WO PCT/US1999/008654 patent/WO1999057100A1/en not_active Application Discontinuation
- 1999-04-20 AU AU36562/99A patent/AU3656299A/en not_active Abandoned
- 1999-04-20 PL PL99343708A patent/PL343708A1/xx unknown
- 1999-04-20 HU HU0102243A patent/HUP0102243A2/hu unknown
- 1999-04-20 US US09/673,675 patent/US6340699B1/en not_active Expired - Fee Related
- 1999-04-20 KR KR1020007012113A patent/KR20010043190A/ko not_active Application Discontinuation
- 1999-04-20 EA EA200001140A patent/EA200001140A1/ru unknown
- 1999-04-20 IL IL13901999A patent/IL139019A0/xx unknown
- 1999-04-20 JP JP2000547070A patent/JP2002513783A/ja not_active Withdrawn
- 1999-04-20 EP EP99918711A patent/EP1084108A4/en not_active Withdrawn
- 1999-04-20 CN CN99805675A patent/CN1299348A/zh active Pending
-
2000
- 2000-10-10 ZA ZA200005563A patent/ZA200005563B/en unknown
- 2000-10-31 NO NO20005479A patent/NO20005479L/no not_active Application Discontinuation
- 2000-10-31 HR HR20000739A patent/HRP20000739A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL343708A1 (en) | 2001-08-27 |
| WO1999057100A1 (en) | 1999-11-11 |
| EP1084108A4 (en) | 2005-01-12 |
| NO20005479D0 (no) | 2000-10-31 |
| IL139019A0 (en) | 2001-11-25 |
| EP1084108A1 (en) | 2001-03-21 |
| AU3656299A (en) | 1999-11-23 |
| CA2330856A1 (en) | 1999-11-11 |
| KR20010043190A (ko) | 2001-05-25 |
| BR9910095A (pt) | 2000-12-26 |
| HRP20000739A2 (en) | 2001-10-31 |
| EA200001140A1 (ru) | 2001-04-23 |
| ID27153A (id) | 2001-03-08 |
| JP2002513783A (ja) | 2002-05-14 |
| NO20005479L (no) | 2000-12-20 |
| CN1299348A (zh) | 2001-06-13 |
| CZ20004052A3 (cs) | 2002-05-15 |
| US6340699B1 (en) | 2002-01-22 |
| ZA200005563B (en) | 2002-01-10 |
| TR200003194T2 (tr) | 2001-03-21 |
| HUP0102243A2 (hu) | 2001-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100496490C (zh) | 用于治疗心血管疾病的血管紧张素ii受体阻断剂氯沙坦、缬沙坦、坎地沙坦、替米沙坦、依普罗沙坦和奥美沙坦的硝基氧基衍生物 | |
| JP4939396B2 (ja) | Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法 | |
| WO2007021682A1 (en) | Method of use of deacetylase inhibitors | |
| US9199917B2 (en) | N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation | |
| JP2002537258A5 (zh) | ||
| US7452910B2 (en) | Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties | |
| SK16342000A3 (sk) | Liečivo na liečbu zápalového ochorenia čreva obsahujúce 1H-indol-3-glyoxylamidy | |
| US6444697B2 (en) | Synthetic compounds for treatment of inflammation | |
| US6436983B1 (en) | Treatment for alzheimer's disease | |
| US20030087944A1 (en) | Method for the treatment of renal dysfunction with spla2 inhibitors | |
| US5409926A (en) | AT-2 antagonist inhibition of vascular restenosis | |
| JP2007131532A (ja) | 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬 | |
| JP4564669B2 (ja) | インドールｓＰＬＡ２インヒビターのモルホリノ−Ｎ−エチルエステル誘導体 | |
| JP2003321424A (ja) | エステル化合物及びその医薬用途 | |
| US6589975B2 (en) | Synthetic compounds for treatment of inflammation | |
| MXPA00010463A (en) | Spla2 | |
| ES2381377T3 (es) | Análogos de piperidinilprostaglandina como agentes hipotensores oculares | |
| WO2023187561A1 (en) | 2-[(2-oxo-4-phenyl-2h-chromen-7-yl)oxy] propanamido derivatives | |
| JP2007505036A (ja) | フェニルカルボキサミドとβ−アドレナリン性受容体遮断剤の組み合わせおよびそれらの心房性不整脈の処置のための使用 | |
| JP2003525901A (ja) | ｓＰＬＡ２インヒビターによる腎臓機能障害の治療方法 | |
| WO2010083633A1 (zh) | 抗高血压化合物及其制备方法、药物组合物和用途 |